Literature DB >> 29237715

Vaccines to combat the opioid crisis: Vaccines that prevent opioids and other substances of abuse from entering the brain could effectively treat addiction and abuse.

Margaret E Olson1,2,3,4, Kim D Janda1,2,3,4.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 29237715      PMCID: PMC5757212          DOI: 10.15252/embr.201745322

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  9 in total

1.  mu Opioid receptor-mediated G-protein activation by heroin metabolites: evidence for greater efficacy of 6-monoacetylmorphine compared with morphine.

Authors:  D E Selley; C C Cao; T Sexton; J A Schwegel; T J Martin; S R Childers
Journal:  Biochem Pharmacol       Date:  2001-08-15       Impact factor: 5.858

2.  The Role of Science in Addressing the Opioid Crisis.

Authors:  Nora D Volkow; Francis S Collins
Journal:  N Engl J Med       Date:  2017-05-31       Impact factor: 91.245

3.  Changes in heroin self-administration by a rhesus monkey after morphine immunisation.

Authors:  K F Bonese; B H Wainer; F W Fitch; R M Rothberg; C R Schuster
Journal:  Nature       Date:  1974-12-20       Impact factor: 49.962

4.  Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs.

Authors:  Paul T Bremer; Atsushi Kimishima; Joel E Schlosburg; Bin Zhou; Karen C Collins; Kim D Janda
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-16       Impact factor: 15.336

5.  An Advance in Prescription Opioid Vaccines: Overdose Mortality Reduction and Extraordinary Alteration of Drug Half-Life.

Authors:  Atsushi Kimishima; Cody J Wenthur; Bin Zhou; Kim D Janda
Journal:  ACS Chem Biol       Date:  2016-11-29       Impact factor: 5.100

6.  Increases in Drug and Opioid-Involved Overdose Deaths - United States, 2010-2015.

Authors:  Rose A Rudd; Puja Seth; Felicita David; Lawrence Scholl
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-12-30       Impact factor: 17.586

7.  Development of a Clinically Viable Heroin Vaccine.

Authors:  Paul T Bremer; Joel E Schlosburg; Matthew L Banks; Floyd F Steele; Bin Zhou; Justin L Poklis; Kim D Janda
Journal:  J Am Chem Soc       Date:  2017-06-20       Impact factor: 15.419

8.  Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats.

Authors:  Marco Pravetoni; Jeffrey S Vervacke; Mark D Distefano; Ashli M Tucker; Megan Laudenbach; Paul R Pentel
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

9.  Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy.

Authors:  Paul T Bremer; Joel E Schlosburg; Jenny M Lively; Kim D Janda
Journal:  Mol Pharm       Date:  2014-02-19       Impact factor: 4.939

  9 in total
  11 in total

Review 1.  Opioid use and misuse: health impact, prevalence, correlates and interventions.

Authors:  Maria Bolshakova; Ricky Bluthenthal; Steve Sussman
Journal:  Psychol Health       Date:  2019-06-08

2.  Inner Workings: Using vaccines to harness the immune system and fight drugs of abuse.

Authors:  Leah Shaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-12-28       Impact factor: 11.205

3.  Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder.

Authors:  Fatima A Hamid; Cheryl L Marker; Michael D Raleigh; Aaron Khaimraj; Scott Winston; Paul R Pentel; Marco Pravetoni
Journal:  Vaccine       Date:  2022-04-22       Impact factor: 4.169

Review 4.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

Review 5.  Immunopharmacotherapies for Treating Opioid Use Disorder.

Authors:  Matthew L Banks; Margaret E Olson; Kim D Janda
Journal:  Trends Pharmacol Sci       Date:  2018-11       Impact factor: 14.819

Review 6.  Risk Factors and Prevention Strategies for Postoperative Opioid Abuse.

Authors:  Shuai Zhao; Fan Chen; Anqi Feng; Wei Han; Yuan Zhang
Journal:  Pain Res Manag       Date:  2019-07-10       Impact factor: 3.037

7.  Design, Synthesis, and In Vivo Evaluation of C1-Linked 4,5-Epoxymorphinan Haptens for Heroin Vaccines.

Authors:  Agnieszka Sulima; Fuying Li; Jeffrey Brian Morgan; Phong Truong; Joshua F G Antoline; Therese Oertel; Rodell C Barrientos; Oscar B Torres; Zoltan Beck; Gregory H Imler; Jeffrey R Deschamps; Gary R Matyas; Arthur E Jacobson; Kenner C Rice
Journal:  Molecules       Date:  2022-02-25       Impact factor: 4.927

8.  Synthesis and immunological effects of C14-linked 4,5-epoxymorphinan analogues as novel heroin vaccine haptens.

Authors:  Eugene S Gutman; Thomas C Irvin; J Brian Morgan; Rodell C Barrientos; Oscar B Torres; Zoltan Beck; Gary R Matyas; Arthur E Jacobson; Kenner C Rice
Journal:  RSC Chem Biol       Date:  2021-04-19

9.  Novel Vaccine That Blunts Fentanyl Effects and Sequesters Ultrapotent Fentanyl Analogues.

Authors:  Rodell C Barrientos; Eric W Bow; Connor Whalen; Oscar B Torres; Agnieszka Sulima; Zoltan Beck; Arthur E Jacobson; Kenner C Rice; Gary R Matyas
Journal:  Mol Pharm       Date:  2020-08-13       Impact factor: 4.939

10.  Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in Mice.

Authors:  Rodell C Barrientos; Connor Whalen; Oscar B Torres; Agnieszka Sulima; Eric W Bow; Essie Komla; Zoltan Beck; Arthur E Jacobson; Kenner C Rice; Gary R Matyas
Journal:  Bioconjug Chem       Date:  2021-06-02       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.